Average cost of multi drug-resistant tuberculosis treatment in Guinea
Guinea: Average cost of multi drug-resistant tuberculosis treatment was 616 constant 2022 US$ in 2024. ◆ Volatile
Latest (2024)
616 constant 2022 US$
Change on year
unchanged
World rank
71st
of 92 countries
All-time high
3,513 constant 2022 US$
in 2021
All-time low
274 constant 2022 US$
in 2020
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Guinea, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Guinea recorded 616 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2024.
Compared with earlier readings it is down 36.4% over ten years.
Guinea ranks 71st of 92 countries on this measure, in the bottom quarter.
Average cost of multi drug-resistant tuberculosis treatment in Guinea, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 969 constant 2022 US$ | — |
| 2018 | 306 constant 2022 US$ | -68.4% |
| 2019 | 306 constant 2022 US$ | +0.0% |
| 2020 | 274 constant 2022 US$ | -10.5% |
| 2021 | 3,513 constant 2022 US$ | +1182.1% |
| 2022 | 616 constant 2022 US$ | -82.5% |
| 2023 | 616 constant 2022 US$ | +0.0% |
| 2024 | 616 constant 2022 US$ | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 527 constant 2022 US$ | 306 constant 2022 US$ | 969 constant 2022 US$ | 3 |
| 2020s | 1,127 constant 2022 US$ | 274 constant 2022 US$ | 3,513 constant 2022 US$ | 5 |
Countries ranked near Guinea
- 68 Fiji 700 constant 2022 US$ compare
- 69 South Sudan 682 constant 2022 US$ compare
- 70 Venezuela, Bolivarian Republic of 674 constant 2022 US$ compare
- 72 Zambia 600 constant 2022 US$ compare
- 73 El Salvador 574 constant 2022 US$ compare
- 74 Panama 572 constant 2022 US$ compare
More health data for Guinea
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8529 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,123 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11,190 deaths (2100)
- Population ages 0-14, female, annual growth rate 1.45 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1998 units per person (2025)
- Population ages 0-14, male, annual growth rate 1.46 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.2057 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Guinea?
- Average cost of multi drug-resistant tuberculosis treatment in Guinea was 616 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Guinea?
- The highest recorded value was 3,513 constant 2022 US$ in 2021.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Guinea?
- The lowest recorded value was 274 constant 2022 US$ in 2020.
- How does Guinea rank for average cost of multi drug-resistant tuberculosis treatment?
- Guinea ranks 71st out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Guinea?
- Over the last ten years it is down 36.4%. The long-run trend across the full record is volatile.
- Where does this Guinea data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.